STOCK TITAN

Planned sale of 5,160 TNYA shares disclosed in Rule 144 notice

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder filed a notice to sell 5,160 shares of common stock under Rule 144 through Morgan Stanley Smith Barney on or about February 17, 2026. The shares have an aggregate market value of $3,318.72 and are listed on the Nasdaq Global Select Market.

The securities relate to common stock acquired on February 17, 2026 via a restricted stock unit grant from the issuer, totaling 13,750 shares. The issuer reports 213,744,535 shares of this class outstanding, providing context for the size of the planned sale.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the TNYA Form 144 filing disclose about planned share sales?

The filing discloses a planned Rule 144 sale of 5,160 shares of common stock with an aggregate market value of $3,318.72. The shares are to be sold through Morgan Stanley Smith Barney on the Nasdaq Global Select Market.

How many TNYA shares are outstanding compared to the amount being sold?

The issuer reports 213,744,535 shares of common stock outstanding. The planned Rule 144 sale covers 5,160 shares, which is a very small fraction of the total outstanding, indicating a limited relative size for this specific transaction.

How were the TNYA shares in the Form 144 acquired?

The common stock referenced in the notice was acquired on February 17, 2026 via a restricted stock unit transaction from the issuer. On that date, the person obtained 13,750 shares, of which a portion is now planned for resale.

Which broker will handle the TNYA Rule 144 share sale?

The planned sale will be executed through Morgan Stanley Smith Barney, specifically its Operations Department located at 2000 Westchester Ave, Purchase, NY 10577-2530. The filing also notes that the shares are traded on the Nasdaq Global Select Market.

What assurance does the seller give about information on TNYA?

The seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. This representation is part of the standard certification included in the Rule 144 notice.
Tenaya Therapeutics, Inc.

NASDAQ:TNYA

TNYA Rankings

TNYA Latest News

TNYA Latest SEC Filings

TNYA Stock Data

142.89M
214.85M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
SOUTH SAN FRANCISCO